| Particulars (Rupees in Crores.) | Jun-2025 | Mar-2025 | Dec-2024 | Sept-2024 | Jun-2024 |
|---|---|---|---|---|---|
Gross Sales | 3,059.33 | 3,220.13 | 3,301.9 | 3,400.5 | 3,223.3 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,059.33 | 3,220.13 | 3,301.9 | 3,400.5 | 3,223.3 |
Other Operating Income | 205.11 | 36.07 | 85.65 | 33.3 | 20.88 |
Other Income | 26.44 | 11.69 | 31.13 | 39.42 | 31.49 |
Total Income | 3,290.88 | 3,267.89 | 3,418.68 | 3,473.21 | 3,275.68 |
Total Expenditure | 3,007.15 | 3,068 | 2,787.32 | 2,831.88 | 2,655.97 |
PBIDT | 283.73 | 199.89 | 631.36 | 641.33 | 619.71 |
Interest | 58.23 | 66.71 | 52.29 | 48.48 | 39.58 |
PBDT | 225.5 | 133.18 | 579.06 | 592.85 | 580.12 |
Depreciation | 129.93 | 125.21 | 122.74 | 120.28 | 117.79 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 109.31 | -3.5 | 103.05 | 135.91 | 146.88 |
Deferred Tax | -60.71 | 7.09 | 5.24 | -17.82 | -24.79 |
Reported Profit After Tax | 46.97 | 4.38 | 348.03 | 354.49 | 340.24 |
Minority Interest After NP | 0.1 | -0.27 | 0.07 | 0.27 | -0.03 |
Net Profit after Minority Interest | 46.87 | 4.65 | 347.96 | 354.21 | 340.27 |
Extra-ordinary Items | -213.92 | -365.73 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 260.79 | 370.38 | 347.96 | 354.21 | 340.27 |
EPS (Unit Curr.) | 1.66 | 0.16 | 12.33 | 12.55 | 12.06 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 9.27 | 6.2 | 19.12 | 18.85 | 19.22 |
PBDTM(%) | 7.37 | 4.13 | 17.53 | 17.43 | 17.99 |
PATM(%) | 1.53 | 0.13 | 10.54 | 10.42 | 10.55 |
Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.
Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.
At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.
Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.
Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.
The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.
Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.
Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.
ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.
The reshuffle comes after VS Mani, the company's current chief, announced early retirement; he will officially retire as chief on May 26, 2025 after an eight-year career with the company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
